115 related articles for article (PubMed ID: 23590339)
1. Transfer of a lipophilic drug (temoporfin) between small unilamellar liposomes and human plasma proteins: influence of membrane composition on vesicle integrity and release characteristics.
Decker C; Steiniger F; Fahr A
J Liposome Res; 2013 Jun; 23(2):154-65. PubMed ID: 23590339
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
Decker C; Schubert H; May S; Fahr A
J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
[TBL] [Abstract][Full Text] [Related]
3. Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).
Holzschuh S; Kaeß K; Fahr A; Decker C
Pharm Res; 2016 Apr; 33(4):842-55. PubMed ID: 26597938
[TBL] [Abstract][Full Text] [Related]
4. Investigations of the influence of liposome composition on vesicle stability and drug transfer in human plasma: a transfer study.
Holzschuh S; Kaeß K; Bossa GV; Decker C; Fahr A; May S
J Liposome Res; 2018 Mar; 28(1):22-34. PubMed ID: 27750473
[TBL] [Abstract][Full Text] [Related]
5. Temoporfin-loaded liposomes: physicochemical characterization.
Kuntsche J; Freisleben I; Steiniger F; Fahr A
Eur J Pharm Sci; 2010 Jul; 40(4):305-15. PubMed ID: 20412853
[TBL] [Abstract][Full Text] [Related]
6. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
[TBL] [Abstract][Full Text] [Related]
7. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction.
Reshetov V; Zorin V; Siupa A; D'Hallewin MA; Guillemin F; Bezdetnaya L
Photochem Photobiol; 2012; 88(5):1256-64. PubMed ID: 22607362
[TBL] [Abstract][Full Text] [Related]
8. The use of asymmetrical flow field-flow fractionation with on-line detection in the study of drug retention within liposomal nanocarriers and drug transfer kinetics.
Hinna AH; Hupfeld S; Kuntsche J; Brandl M
J Pharm Biomed Anal; 2016 May; 124():157-163. PubMed ID: 26950903
[TBL] [Abstract][Full Text] [Related]
9. Relevance of lipid polar headgroups on boron-mediated changes in membrane physical properties.
Verstraeten SV; Lanoue L; Keen CL; Oteiza PI
Arch Biochem Biophys; 2005 Jun; 438(1):103-10. PubMed ID: 15882836
[TBL] [Abstract][Full Text] [Related]
10. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
11. Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies.
Dragicevic-Curic N; Scheglmann D; Albrecht V; Fahr A
Colloids Surf B Biointerfaces; 2009 May; 70(2):198-206. PubMed ID: 19188048
[TBL] [Abstract][Full Text] [Related]
12. Transfer mechanism of temoporfin between liposomal membranes.
Hefesha H; Loew S; Liu X; May S; Fahr A
J Control Release; 2011 Mar; 150(3):279-86. PubMed ID: 20888878
[TBL] [Abstract][Full Text] [Related]
13. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
15. Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies.
Dragicevic-Curic N; Scheglmann D; Albrecht V; Fahr A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):114-22. PubMed ID: 19651496
[TBL] [Abstract][Full Text] [Related]
16. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
[TBL] [Abstract][Full Text] [Related]
17. Liposome preparation using a hollow fiber membrane contactor--application to spironolactone encapsulation.
Laouini A; Jaafar-Maalej C; Sfar S; Charcosset C; Fessi H
Int J Pharm; 2011 Aug; 415(1-2):53-61. PubMed ID: 21641982
[TBL] [Abstract][Full Text] [Related]
18. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
[TBL] [Abstract][Full Text] [Related]
19. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
[TBL] [Abstract][Full Text] [Related]
20. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
Chen M; Liu X; Fahr A
Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
